Can Fite Correlations
| CANF Stock | USD 1.96 0.01 0.51% |
The current 90-days correlation between Can Fite Biopharma and Evogene is 0.18 (i.e., Average diversification). The correlation of Can Fite is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Can Fite Correlation With Market
Average diversification
The correlation between Can Fite Biopharma and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Can Fite Biopharma and DJI in the same portfolio, assuming nothing else is changed.
Can |
Moving together with Can Stock
Moving against Can Stock
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Can Stock performing well and Can Fite Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Can Fite's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ICCC | 1.75 | 0.14 | (0.02) | (0.09) | 2.33 | 3.40 | 21.64 | |||
| CGEN | 2.58 | (0.78) | 0.00 | (0.23) | 0.00 | 5.23 | 16.24 | |||
| EVGN | 3.83 | (1.12) | 0.00 | (1.98) | 0.00 | 9.30 | 36.00 | |||
| CLGN | 2.43 | (0.43) | 0.00 | (0.28) | 0.00 | 4.69 | 14.36 | |||
| PLX | 3.22 | 1.07 | 0.26 | (1.42) | 2.54 | 10.00 | 20.38 | |||
| CRVS | 3.66 | 1.08 | 0.28 | 0.76 | 3.07 | 9.38 | 23.11 | |||
| ALDX | 2.82 | (0.27) | 0.00 | (0.03) | 0.00 | 6.69 | 22.45 | |||
| GMDA | 3.41 | (0.07) | 0.00 | 0.33 | 0.00 | 6.81 | 28.30 | |||
| CKPT | 3.12 | 0.79 | 0.19 | 4.89 | 3.09 | 7.91 | 19.17 | |||
| CADL | 3.25 | (0.21) | (0.03) | 0.01 | 3.78 | 6.70 | 22.01 |
Can Fite Corporate Management
| Motti Farbstein | Chief Operating and Financial Officer and Principal Accounting Officer | Profile | |
| Sari Fishman | Vice Development | Profile | |
| Ilan Cohn | CoFounder Chairman | Profile | |
| FACP FACR | Clinical Advisor | Profile | |
| MD FACP | Member Officer | Profile |